Brain region-specific gene expression profiles in freshly isolated rat microglia

Frontiers in Cellular Neuroscience

Volumn 9, Issue , 2015, Pages

  Doorn, Karlijn J ^a,b   Brevé, John J P ^b   Drukarch, Benjamin ^b   Boddeke, Hendrikus W ^c   Huitinga, Inge ^d   Lucassen, Paul J ^a   van Dam, Anne Marie ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

FACS; Hippocampus; Microglia; Olfactory bulb; Parkinson s disease; Substantia nigra

Indexed keywords

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL SUSPENSION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; DNA SYNTHESIS; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION PROFILING; HIPPOCAMPUS; MALE; MICROGLIA; NONHUMAN; PARKINSON DISEASE; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; SEQUENCE ALIGNMENT;

EID: 84939618789     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00084     Document Type: Article

References (93)

1. Aloisi, F. (2001). Immune function of microglia. Glia 36, 165-179. doi: 10.1002/glia.1106
2. Amino, T., Orimo, S., Itoh, Y., Takahashi, A., Uchihara, T., and Mizusawa, H. (2005). Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol. 15, 29-34. doi: 10.1111/j.1750-3639.2005.tb00097.x
3. Beraud, D., Twomey, M., Bloom, B., Mittereder, A., Ton, V., Neitzke, K., et al. (2011). α-Synuclein alters toll-like receptor expression. Front. Neurosci. 5:80. doi: 10.3389/fnins.2011.00080
4. Borrajo, A., Rodriguez-Perez, A. I., Diaz-Ruiz, C., Guerra, M. J., and Labandeira-Garcia, J. L. (2014). Microglial TNFα mediates enhancement of dopaminergic degeneration by brain angiotensin. Glia 62, 145-157. doi: 10.1002/glia.22595
5. Braak, H., and Braak, E. (2000). Pathoanatomy of Parkinson's disease. J. Neurol. 247, 3-10. doi: 10.1007/PL00007758
6. Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., and Del Tredici, K. (2004). Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318, 121-134. doi: 10.1007/s00441-004-0956-9
7. Burnstock, G., Krügel, U., Abbracchio, M. P., and Illes, P. (2011). Purinergic signalling: from normal behaviour to pathological brain function. Prog. Neurobiol. 95, 229-274. doi: 10.1016/j.pneurobio.2011.08.006
8. Buschmann, J. P., Berger, K., Awad, H., Clarner, T., Beyer, C., and Kipp, M. (2012). Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination. J. Mol. Neurosci. 48, 66-76. doi: 10.1007/s12031-012-9773-x
9. Campos, R. C., Parfitt, G. M., Polese, C. E., Coutinho-Silva, R., Morrone, F. B., and Barros, D. M. (2014). Pharmacological blockage and P2X7 deletion hinder aversive memories: reversion in an enriched environment. Neuroscience 280, 220-230. doi: 10.1016/j.neuroscience.2014.09.017
10. Carmo, M. R., Menezes, A. P., Nunes, A. C., Pliássova, A., Rolo, A. P., Palmeira, C. M., et al. (2014). The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis. Neuropharmacology 81, 142-152. doi: 10.1016/j.neuropharm.2014.01.045
11. Chu, Y. X., Zhang, Y., Zhang, Y. Q., and Zhao, Z. Q. (2010). Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses. Brain. Behav. Immun. 24, 1176-1189. doi: 10.1016/j.bbi.2010.06.001
12. Conde, J. R., and Streit, W. J. (2006). Microglia in the aging brain. J. Neuropathol. Exp. Neurol. 65, 199-203. doi: 10.1097/01.jnen.0000202887.22082.63
13. Czeh, M., Gressens, P., and Kaindl, A. M. (2011). The Yin and Yang of Microglia. Dev. Neurosci. 33, 199-209. doi: 10.1159/000328989
14. David, S., and Kroner, A. (2011). Repertoire of microglial and macrophage responses after spinal cord injury. Nat. Rev. Neurosci. 12, 388-399. doi: 10.1038/nrn3053
15. De Haas, A. H., Boddeke, H. W., and Biber, K. (2008). Region specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 56, 888-894. doi: 10.1002/glia.20663
16. Dickson, D. W., Fujishiro, H., Orr, C., DelleDonne, A., Josephs, K. A., Frigerio, R., et al. (2009). Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat. Disord. 15, S1-S5. doi: 10.1016/S1353-8020(09)70769-2
17. Doorn, K. J., Drukarch, B., van Dam, A. M., and Lucassen, P. J. (2014a). Hippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia. Neural. Plas. 2014, 13. doi: 10.1155/2014/959154
18. Doorn, K. J., Moors, T., Drukarch, B., van de Berg, W. D. J., Lucassen, P. J., and van Dam, A. M. (2014b). Microglial phenotypes and Toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients. Acta Neuropathol. Commun. 90, 1-17. doi: 10.1186/s40478-014-0090-1
19. Doorn, K. J., Goudriaan, A., Blits-Huizinga, C., Bol, J. G., Rozemuller, A. J., Hoogland, P. V., et al. (2013). Increased amoeboid microglial density in the olfactory bulb of Parkinson's and Alzheimer's patients. Brain Pathol. 24, 152-165. doi: 10.1111/bpa.12088
20. Doorn, K. J., Lucassen, P. J., Boddeke, H. W., Prins, M., Berendse, H. W., Drukarch, B.et al. (2012). Emerging roles of microglial activation and non-motor symptoms in Parkinson's disease. Prog. Neurobiol. 98, 222-238. doi: 10.1016/j.pneurobio.2012.06.005
21. Eggen, B. J. L., Raj, D., Hanisch, U. K., and Boddeke, H. W. (2013). Microglial phenotype and adaptation. J. Neuroimmune Pharmacol. 8, 807-823. doi: 10.1007/s11481-013-9490-4
22. Ekdahl, C. T., Claasen, J. H., Bonde, S., Kokaia, Z., and Lindvall, O. (2003). Inflammation is detrimental for neurogenesis in adult brain. Proc. Natl. Acad. Sci. U.S.A. 100, 13632-13637. doi: 10.1073/pnas.2234031100
23. El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., et al. (2007). Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat. Med. 13, 432-438. doi: 10.1038/nm1555
24. Ford, A. L., Foulcher, E., Goodsall, A. L., and Sedgwick, J. D. (1996). Tissue digestion with dispase substantially reduces lymphocyte and macrophage cell-surface antigen expression. J. Immunol. Methods. 194, 71-75. doi: 10.1016/0022-1759(96)00067-1
25. Frank, M. G., Wieseler-Frank, J. L., Watkins, L. R., and Maier, S. F. (2006). Rapid isolation of highly enriched and quiescent microglia from adult rat hippocampus: immunophenotypic and functional characteristics. J. Neurosci. Methods 151, 121-130. doi: 10.1016/j.jneumeth.2005.06.026
26. Gordon, S., and Martinez, F. O. (2010). Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604. doi: 10.1016/j.immuni.2010.05.007
27. Halliday, G. M., and Stevens, C. H. (2011). Glia: initiators and progressors of pathology in Parkinson's disease. Mov. Disord. 26, 6-17. doi: 10.1002/mds.23455
28. Hanisch, U. K. (2002). Microglia as a source and target of cytokines. Glia 40, 140-155. doi: 10.1002/glia.10161
29. Hanisch, U. K., and Kettenmann, H. (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394. doi: 10.1038/nn1997
30. Hart, A. D., Wyttenbach, A., Perry, V. H., and Teeling, J. L. (2012). Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences. Brain. Behav. Immun. 26, 754-765. doi: 10.1016/j.bbi.2011.11.006
31. Hinojosa, A. E., Garcia-Bueno, B., Leza, J. C., and Madrigal, J. L. (2011). CCL2/MCP-1 modulation of microglial activation and proliferation. J. Neuroinflammation 8, 77-77. doi: 10.1186/1742-2094-8-77
32. Hirsch, E. C., Vyas, S., and Hunot, S. (2012). Neuroinflammation in Parkinson's disease. Parkinsonism Relat. Disord. 18, 210-212. doi: 10.1016/S1353-8020(11)70065-7
33. Holness, C. L., and Simmons, D. L. (1993). Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81, 1607-1613.
34. Imamura, K., Hishikawa, N., Sawada, M., Nagatsu, T., Yoshida, M., and Hashizume, Y. (2003). Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol. 106, 518-526. doi: 10.1007/s00401-003-0766-2
35. Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., and Kohsaka, S. (1998). Microglia-specific localisation of a novel calcium binding protein, Iba1. Mol. Brain Res. 57, 1-9. doi: 10.1016/S0169-328X(98)00040-0
36. Jellinger, K. A. (2011). Synuclein deposition and non-motor symptoms in Parkinson disease. J. Neurol. Sci. 310, 107-111. doi: 10.1016/j.jns.2011.04.012
37. Kettenmann, H., Hanisch, U. K., Noda, M., and Verkhratsky, A. (2011). Physiology of microglia. Physiol. Rev. 91, 461-553. doi: 10.1152/physrev.00011.2010
38. Kigerl, K. A., Gensel, J. C., Ankeny, D. P., Alexander, J. K., Donnelly, D. J., and Popovich, P. G. (2009). Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J. Neurosci. 29, 13435-13444. doi: 10.1523/JNEUROSCI.3257-09.2009
39. Kim, C., Ho, D. H., Suk, J. E., You, S., Michael, S., Kang, J., et al. (2013). Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat. Commun. 4, 1562. doi: 10.1038/ncomms2534
40. Kim, W. G., Mohney, R. P., Wilson, B., Jeohn, G. H., Liu, B., and Hong, J. S. (2000). Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309-6316.
41. Kraft, A. D., McPherson, C. A., and Harry, G. J. (2009). Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survival. Neurotoxicology. 30, 785-793. doi: 10.1016/j.neuro.2009.07.001
42. Lacombe, F., Durrieu, F., Briais, A., Dumain, P., Belloc, F., Bascans, E., et al. (1997). Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia. Leukemia 11, 1878-1886. doi: 10.1038/sj.leu.2400847
43. Lawson, L. J., Perry, V. H., Dri, P., and Gordon, S. (1990). Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience 39, 151-170. doi: 10.1016/0306-4522(90)90229-W
44. Lim, J. H., and Brunjes, P. C. (1999). Activity-dependent regulation of interleukin-1β immunoreactivity in the developing rat olfactory bulb. Neuroscience 93, 371-374. doi: 10.1016/S0306-4522(99)00093-7
45. Lucin, K. M., and Wyss-Coray, T. (2009). Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 64, 110-122. doi: 10.1016/j.neuron.2009.08.039
46. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., and Locati, M. (2004). The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686. doi: 10.1016/j.it.2004.09.015
47. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., and Sica, A. (2002). Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23, 549-555. doi: 10.1016/S1471-4906(02)02302-5
48. McGeer, P. L., Itagaki, S., Boyes, B. E., and McGeer, E. G. (1988). Reactive microglia are positive for HLA DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1286. doi: 10.1212/WNL.38.8.1285
49. McGeer, P. L., and McGeer, E. G. (2008). Glial reactions in Parkinson's disease. Mov. Disord. 23, 474-483. doi: 10.1002/mds.21751
50. McLarnon, J. G., Ryu, J. K., Walker, D. G., and Choi, H. B. (2006). Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-[beta] peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol. 65, 1090-1097. doi: 10.1097/01.jnen.0000240470.97295.d3
51. Melief, J., Koning, N., Schuurman, K. G., Van De Garde, M. D., Smolders, J., Hoek, R. M., et al. (2012). Phenotyping primary human microglia: tight regulation of LPS responsiveness. Glia 60, 1506-1517. doi: 10.1002/glia.22370
52. Melief, J., Schuurman, K. G., Garde, M. D., Smolders, J., Eijk, M., Hamann, J., et al. (2013). Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed. Glia 61, 1848-1861. doi: 10.1002/glia.22562
53. Mittelbronn, M., Dietz, K., Schluesener, H. J., and Meyermann, R. (2001). Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude. Acta Neuropathol. 101, 249-255.
54. Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., and Nagatsu, T. (1994). Tumor necrosis factor-[alpha](TNF-[alpha]) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165, 208-210. doi: 10.1016/0304-3940(94)90746-3
55. Mori, M., Heuss, C., Gähwiler, B. H., and Gerber, U. (2001). Fast synaptic transmission mediated by P2X receptors in CA3 pyramidal cells of rat hippocampal slice cultures. J. Physiol. 535, 115-123. doi: 10.1111/j.1469-7793.2001.t01-1-00115.x
56. Mosser, D. M., and Edwards, J. P. (2008). Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8, 958-969. doi: 10.1038/nri2448
57. Ni, J., Wang, P., Zhang, J., Chen, W., and Gu, L. (2013). Silencing of the P2X(7) receptor enhances amyloid-β phagocytosis by microglia. Biochem. Biophys. Res. Commun. 434, 363-369. doi: 10.1016/j.bbrc.2013.03.079
58. Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005). Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318. doi: 10.1126/science.1110647
59. Olah, M., Biber, K., Vinet, J., and Boddeke, H. W. G. M. (2011). Microglia phenotype diversity. CNS Neurol. Disord. Drug Targets 10, 108-118. doi: 10.2174/187152711794488575
60. Olah, M., Raj, D., Brouwer, N., De Haas, A. H., Eggen, B. J. L., Den Dunnen, W. F. A., et al. (2012). An optimized protocol for the acute isolation of human microglia from autopsy brain samples. Glia 60, 96-111. doi: 10.1002/glia.21251
61. Orimo, S., Takahashi, A., Uchihara, T., Mori, F., Kakita, A., Wakabayashi, K., et al. (2007). Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol. 17, 24-30. doi: 10.1111/j.1750-3639.2006.00032.x
62. Orre, M., Kamphuis, W., Osborn, L. M., Melief, J., Kooijman, L., Huitinga, I., et al. (2014). Acute isolation and transcriptome characterization of cortical astrocytes and microglia from young and aged mice. Neurobiol. Aging 35, 1-14. doi: 10.1016/j.neurobiolaging.2013.07.008
63. Pankratov, Y. V., Lalo, U. V., and Krishtal, O. A. (2002). Role for P2X receptors in long-term potentiation. J. Neurosci. 22, 8363-8369.
64. Pankratov, Y., Lalo, U., Krishtal, O. A., and Verkhratsky, A. (2009). P2X receptors and synaptic plasticity. Neuroscience 158, 137-148. doi: 10.1016/j.neuroscience.2008.03.076
65. Peng, Z. C., Kristensson, K., and Bentivoglio, M. (1998). Distribution and temporal regulation of the immune response in the rat brain to intracerebroventricular injection of interferon-y. Exp. Neurol. 154, 403-417. doi: 10.1006/exnr.1998.6943
66. Perry, V. H., Cunningham, C., and Holmes, C. (2007). Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7, 161-167. doi: 10.1038/nri2015
67. Perry, V. H., Matyszak, M. K., and Fearn, S. (1993). Altered antigen expression of microglia in the aged rodent CNS. Glia 7, 60-67. doi: 10.1002/glia.440070111
68. Perry, V. H., Nicoll, J. A. R., and Holmes, C. (2010). Microglia in neurodegenerative disease. Nat. Rev. Neurol. 6, 193-201. doi: 10.1038/nrneurol.2010.17
69. Prins, M., Dutta, R., Baselmans, B., Brevé, J. J. P., Bol, J. G. J. M., Deckard, S. A., et al. (2014). Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients. Acta neuropathol. Commun. 2, 98. doi: 10.1186/s40478-014-0098-6 [Epub ahead of print].
70. Ransohoff, R. M., and Perry, V. H. (2009). Microglial physiology: unique stimuli, specialized responses. Annu. Rev. Immunol. 27, 119-145. doi: 10.1146/annurev.immunol.021908.132528
71. Ren, L. Q., Lubrich, B., Biber, K., and Gebicke-Haerter, P. J. (1999). Differential expression of inflammatory mediators in rat microglia cultured from different brain regions. Mol. Brain Res. 65, 198-205. doi: 10.1016/S0169-328X(99)00016-9
72. Rothwell, N. J. (1991). Functions and mechanisms of interleukin 1 in the brain. Trends Pharmacol. Sci. 12, 430-436. doi: 10.1016/0165-6147(91)90623-Z
73. Roy, A., Fung, Y. K., Liu, X., and Pahan, K. (2006). Up-regulation of microglial CD11b expression by nitric oxide. J. Biol. Chem. 281, 14971-14980. doi: 10.1074/jbc.M600236200
74. Ruijter, J. M., Ramakers, C., Hoogaars, W. M. H., Karlen, Y., Bakker, O., and Van den Hoff, M. J. B. (2009). Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 37, e45-e45. doi: 10.1093/nar/gkp045
75. Sedgwick, J. D., Schwender, S., Imrich, H., Dörries, R., Butcher, G. W., and ter Meulen, V. (1991). Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. U.S.A. 88, 7438-7442. doi: 10.1073/pnas.88.16.7438
76. Shieh, C.-H., Heinrich, A., Serchov, T., Calker, D., and Biber, K. (2014). P2X7 dependent, but differentially regulated release of IL 6, CCL2, and TNF α in cultured mouse microglia. Glia 62, 592-607. doi: 10.1002/glia.22628
77. Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., and O'Callaghan, J. P. (2002). Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J. 16, 1474-1476.
78. Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., and O'Callaghan, J. P. (2006). Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP-induced neurotoxicity: role of TNF-α. FASEB J. 20, 670-682. doi: 10.1096/fj.05-5106com
79. Stirling, D. P., and Yong, V. W. (2008). Dynamics of the inflammatory response after murine spinal cord injury revealed by flow cytometry. J. Neurosci. Res. 86, 1944-1958. doi: 10.1002/jnr.21659
80. Taylor, D. L., Jones, F., Kubota, E. S., and Pocock, J. M. (2005). Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor α induced neurotoxicity in concert with microglial-derived Fas ligand. J. Neurosci. 25, 2952-2964. doi: 10.1523/JNEUROSCI.4456-04.2005
81. Torres-Platas, S. G., Comeau, S., Rachalski, A., Dal Bo, G., Cruceanu, C., Turecki, G., et al. (2014). Morphometric characterization of microglial phenotypes in human cerebral cortex. J. Neuroinflamm. 11, 12. doi: 10.1186/1742-2094-11-12
82. van Dam, A. M., Brouns, M., Louisse, S., and Berkenbosch, F. (1992). Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res. 588, 291-296. doi: 10.1016/0006-8993(92)91588-6
83. Vroon, A., Drukarch, B., Bol, J. G. J. M., Cras, P., Brevé, J. J. P., and Allan, S. M., et al. (2007). Neuroinflammation in Parkinson's patients and MPTP-treated mice is not restricted to the nigrostriatal system: microgliosis and differential expression of interleukin-1 receptors in the olfactory bulb. Exp. Gerontol. 42, 762-771. doi: 10.1016/j.exger.2007.04.010
84. Wake, H., Moorhouse, A. J., Miyamoto, A., and Nabekura, J. (2013). Microglia: actively surveying and shaping neuronal circuit structure and function. Trends Neurosci. 36, 209-217. doi: 10.1016/j.tins.2012.11.007
85. Walter, L., and Neumann, H. (2009). Role of microglia in neuronal degeneration and regeneration. Semin. Immunopathol. 31, 513-525. doi: 10.1007/s00281-009-0180-5
86. Wang, P., Rothwell, N. J., Pinteaux, E., and Brough, D. (2008). Neuronal injury induces the release of pro-interleukin-1beta from activated microglia in vitro. Brain Res. 1236, 1-7. doi: 10.1016/j.brainres.2008.08.001
87. Watson, M. B., Richter, F., Lee, S. K., Gabby, L., Wu, J., Masliah, E., et al. (2012). Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein. Exp. Neurol. 237, 318-334. doi: 10.1016/j.expneurol.2012.06.025
88. Welser, J. V., Li, L., and Milner, R. (2010). Microglial activation state exerts a biphasic influence on brain endothelial cell proliferation by regulating the balance of TNF and TGF- 1. J. Neuroinflamm. 7, 89-96. doi: 10.1186/1742-2094-7-89
89. Wieraszko, A. (1996). Extracellular ATP as a neurotransmitter: its role in synaptic plasticity in the hippocampus. Acta Neurobiol. Exp. (Warsz) 56, 637-648.
90. Wong, A. M., Patel, N. V., Patel, N. K., Wei, M., Morgan, T. E., de Beer, M. C., et al. (2005). Macrosialin increases during normal brain aging are attenuated by caloric restriction. Neurosci. Lett. 390, 76-80. doi: 10.1016/j.neulet.2005.07.058
91. Xie, Z., Morgan, T. E., Rozovsky, I., and Finch, C. E. (2003). Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity. Exp. Neurol. 182, 135-141. doi: 10.1016/S0014-4886(03)00057-8
92. Zhang, G. X., Li, J., Ventura, E., and Rostami, A. (2002). Parenchymal microglia of naïve adult C57BL/6J mice express high levels of B7. 1, B7. 2, and MHC class II. Exp. Mol. Pathol. 73, 35-45. doi: 10.1006/exmp.2002.2441
93. Zou, J., Vetreno, R. P., and Crews, F. T. (2012). ATP P2X7 receptor signaling controls basal and TNF-α stimulated glial cell proliferation. Glia 60, 661-673. doi: 10.1002/glia.22302